Multiple dimensions of cell-free DNA in lymphomas. The study from Meriranta et al examines multiple aspects of cell-free DNA in large B-cell lymphomas, including pretreatment disease quantification (A), molecular response assessment (B), mutational genotyping (C), and DNA fragmentation patterns (D). Each feature of cell-free DNA molecules has potential for translation into the clinic as a prognostic biomarker.